Plus   Neg

GSK Submits Daprodustat For Approval In Japan To Treat Renal Anaemia Due To CKD

GlaxoSmithKline plc (GSK.L,GSK) Wednesday announced that it has submitted a Japanese New Drug Application or JNDA to the Ministry of Health, Labour and Welfare seeking marketing approval for daprodustat to treat patients with renal anaemia due to chronic kidney disease or CKD.

Daprodustat is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor or HIF-PHI. The company noted that HIF-PHIs are a new class of drug that trigger the body's adaptations to hypoxia and encourage the bone marrow to make more red blood cells, thereby benefitting patients with renal anaemia.

GSK said the JNDA for daprodustat is primarily based on positive data from the phase 3 programme conducted in Japan. The studies evaluated daprodustat for the treatment of anaemia in patients across the spectrum of CKD from stages 3-5.

Daprodustat is not approved as a treatment for renal anaemia or any other indication anywhere in the world.

If approved, daprodustat will be exclusively distributed in Japan by Kyowa Kirin Co., Ltd., following the strategic commercialisation deal announced in 2018.

GSK and Kyowa Kirin would jointly conduct launch activities, including engagement of healthcare professionals and commercial activities.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Toyota Motor Corp. has invested $394 million in U.S. electric air-taxi startup Joby Aviation as lead investor in the recent $590 million Series C financing. Toyota said it is continuing to leverage emerging technologies to provide "Mobility for All" as the lead investor as part of its transformation into a mobility company. As the world is facing severe consequences of increasing carbon emissions, Microsoft has announced various plans to tackle the issue. The company aims to reduce its own carbon emissions by more than half, and to be carbon negative by 2030. This means the company will remove more carbon than it emits each year. The company further announced a new $1 billion Climate Innovation Fund. With a view to expanding its presence in France, where it has been doing business for more than 100 years, Food and beverage giant Coca-Cola Co. (KO), during the Choose France Summit, announced 1 billion euros of investments in the country over the next five years. Coca-Cola Chairman and CEO James Quincey and President Emmanuel Macron is scheduled to elaborate on the plans in September.
Follow RTT